[Federal Register Volume 68, Number 231 (Tuesday, December 2, 2003)]
[Notices]
[Page 67474]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-29971]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated June 25, 2003 and published in the Federal Register 
on July 14, 2003, (68 FR 41661), Cambrex North Brunswick, Inc., 
Technology Center of New Jersey, 661 Highway One, North Brunswick, New 
Jersey 08902, made application by renewal to the Drug Enforcement 
Administration (DEA) to be registered as an importer of Phenylacetone 
(8501), a basic class of controlled substance listed in Schedule II.
    The firm plans to import the listed controlled substance to 
manufacture amphetamine.
    No comments or objections have been received. DEA has considered 
the factors in title 21, United States Code, section 823(a) and 
determined that the registration of Cambrex North Brunswick, Inc. to 
import the listed controlled substance is consistent with the public 
interest and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated Cambrex North Brunswick, Inc. on a regular 
basis to ensure that the company's continued registration is consistent 
with the public interest. This investigation included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with state and local laws, and a review of the 
company's background and history. Therefore, pursuant to Section 
1008(a) of the Controlled Substances Import and Export Act and in 
accordance with title 21, Code of Federal Regulations, section 1301.34, 
the above firm is granted registration as an importer of the basic 
class of controlled substance listed above.

    Dated: November 14, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-29971 Filed 12-1-03; 8:45 am]
BILLING CODE 4410-09-M